array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(25) "ROCHE DIAGNOSTICS LIMITED"
["slug"]=>
string(34) "ef866-gb-roche-diagnostics-limited"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/5ce04174-8fff-4069-9bd1-2ef80ada854c"
["description"]=>
string(1583) "Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).
For more information, please visit https://careers.roche.com/global/en
Read our community guidelines here:
https://www.roche.com/some-guidelines.htm
#Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation"
["address_street"]=>
string(14) "Charles Avenue"
["address_place"]=>
string(12) "BURGESS HILL"
["address_region"]=>
NULL
["founding_date"]=>
string(10) "1956-09-14"
["website_domain"]=>
string(9) "roche.com"
["website_url"]=>
string(29) "https://diagnostics.roche.com"
["industry_codes"]=>
array(1) {
[0]=>
string(43) "Business Services, Not Elsewhere Classified"
}
["employee_count"]=>
int(658)
["article_count"]=>
int(3311)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(70) "The symptoms of Parkinson's disease can be slowed down with antibodies"
["snippet_en"]=>
string(170) "Monthly infusions of an antibody drug called prasinezumab appear to slow the progression of symptoms in people with advanced Parkinson's disease, Nature Medicine reports."
["url"]=>
string(115) "https://www.rynekzdrowia.pl/Polityka-zdrowotna/Przeciwciala-moga-spowolnic-postep-choroby-Parkinsona,257551,14.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/c4c2da2c-a0dd-4d74-a5b9-8ec4d4ce6f7a"
["source"]=>
string(15) "rynekzdrowia.pl"
["publication_date"]=>
string(10) "2024-04-17"
["categories"]=>
array(0) {
}
}
[1]=>
array(7) {
["title_en"]=>
string(71) "School of the Art Institute, Chicago Flaxman Library, USA - e-architect"
["snippet_en"]=>
string(139) "Kwong Von Glinow designed the renovation of the Flaxman Library by combining library space into one inter-connected learning and social hub"
["url"]=>
string(91) "https://www.e-architect.com/chicago/school-of-the-art-institute-chicago-flaxman-library-usa"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/0e62f3d3-8806-4c88-a4de-cae34bef5922"
["source"]=>
string(15) "e-architect.com"
["publication_date"]=>
string(10) "2024-04-16"
["categories"]=>
array(1) {
[0]=>
string(10) "Renovation"
}
}
[2]=>
array(7) {
["title_en"]=>
string(90) "Johnson & Johnson regains the throne by being the 'pharma' with the highest income in 2023"
["snippet_en"]=>
string(327) "The 'ranking' of the pharmaceutical companies with the most turnover has changed from one year to the next. In 2023 Johnson & Johnson regained the throne after Pfizer snatched it away a year earlier. The multinational managed to earn 79,906 million, that is, 6.5% more than in 2022 (75,055 million), according to Fierce Pharma."
["url"]=>
string(141) "https://www.eleconomista.es/salud/noticias/12769612/04/24/johnson-johnson-recupera-el-trono-al-ser-la-farma-con-mayores-ingresos-en-2023.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/fdf5f8b1-5bb0-44b1-b711-837945e644f6"
["source"]=>
string(15) "eleconomista.es"
["publication_date"]=>
string(10) "2024-04-15"
["categories"]=>
array(0) {
}
}
[3]=>
array(7) {
["title_en"]=>
string(59) "Roche Lands Breakthrough Designation for Alzheimer’s Test"
["snippet_en"]=>
string(136) "The Basel, Switzerland-based company’s test looks for the presence of amyloid pathology in patients suspected of having Alzheimer’s."
["url"]=>
string(88) "https://www.mddionline.com/ivd/roche-lands-breakthrough-designation-for-alzheimer-s-test"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/964b11d3-9f65-4542-96ed-5a73028c7fca"
["source"]=>
string(14) "mddionline.com"
["publication_date"]=>
string(10) "2024-04-15"
["categories"]=>
array(2) {
[0]=>
string(5) "R & D"
[1]=>
string(13) "Collaboration"
}
}
[4]=>
array(7) {
["title_en"]=>
string(72) "La Roche-sur-Yon: why the airport is focusing on business aviation (2/2)"
["snippet_en"]=>
string(127) "Created in 2012, the GIE has grown in 12 years from 4 to 55 companies. These are mainly structures from Vendée, but also a few"
["url"]=>
string(117) "https://www.informateurjudiciaire.fr/actualites/la-roche-sur-yon-pourquoi-laeroport-mise-sur-laviation-daffaires-2-2/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/adadfb99-9044-4f85-a792-d378e093e451"
["source"]=>
string(24) "informateurjudiciaire.fr"
["publication_date"]=>
string(10) "2024-04-15"
["categories"]=>
array(0) {
}
}
[5]=>
array(7) {
["title_en"]=>
string(36) "Handball: The U17s return to victory"
["snippet_en"]=>
string(232) "The U17s won at home after three consecutive defeats. Jean-Baptiste Marty archives After three matches without a victory, the Périgueux U17s found their way back to success with a victory over La Roche-sur-Yon this weekend (33-28)."
["url"]=>
string(83) "https://www.dordognelibre.fr/2024/04/15/handball-les-u17-renouent-avec-la-victoire/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/ea073113-3e2e-4b0c-9add-19a1843e3999"
["source"]=>
string(16) "dordognelibre.fr"
["publication_date"]=>
string(10) "2024-04-15"
["categories"]=>
array(0) {
}
}
[6]=>
array(7) {
["title_en"]=>
string(87) "Acute Intermittent Porphyria Market Changes in 2024: Strategies for Survival and Growth"
["snippet_en"]=>
string(87) "Acute Intermittent Porphyria Market Changes in 2024: Strategies for Survival and Growth"
["url"]=>
string(145) "https://industrytoday.co.uk/market-research-industry-today/acute-intermittent-porphyria-market-changes-in-2024-strategies-for-survival-and-growth"
["image_url"]=>
NULL
["source"]=>
string(19) "industrytoday.co.uk"
["publication_date"]=>
string(10) "2024-04-15"
["categories"]=>
array(1) {
[0]=>
string(15) "Market Movement"
}
}
[7]=>
array(7) {
["title_en"]=>
string(30) "Les Brutales Rurales send wood"
["snippet_en"]=>
string(178) "Barely three years old, and the Roller Derby Gers de Fleurance association is organizing its first “Tournoisol” to compete against the teams from Bayonne, Toulouse and Léon."
["url"]=>
string(124) "https://presselib.com/article/brutales-rurales-roller-derby-gers-fleurance-tournoisol-kontra-bandista-pink-block-roll-landes"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/374a789d-74ab-407a-b1c5-d34b304a770f"
["source"]=>
string(13) "presselib.com"
["publication_date"]=>
string(10) "2024-04-14"
["categories"]=>
array(0) {
}
}
[8]=>
array(7) {
["title_en"]=>
string(52) "No. 14 Wake Forest Crushes BC 13–1 — The Heights"
["snippet_en"]=>
string(132) "In Boston College baseball's first game against the No. 14 Demon Deacons, the Eagles lost 13–1 after four eighth-inning home runs."
["url"]=>
string(74) "https://www.bcheights.com/2024/04/14/wake-forest-defeats-bc-baseball-13-1/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/6ec20364-4db9-4baf-8d5e-f48c6fed70a6"
["source"]=>
string(13) "bcheights.com"
["publication_date"]=>
string(10) "2024-04-14"
["categories"]=>
array(0) {
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(216)
}
[1]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(199)
}
[2]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(185)
}
[3]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(153)
}
[4]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(152)
}
[5]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(145)
}
[6]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(134)
}
[7]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(126)
}
[8]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(108)
}
[9]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(104)
}
[10]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(101)
}
[11]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(95)
}
[12]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(91)
}
[13]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(85)
}
[14]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(84)
}
[15]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(69)
}
[16]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(64)
}
[17]=>
array(2) {
["name"]=>
string(13) "Data Security"
["count"]=>
int(63)
}
[18]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(53)
}
[19]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(49)
}
[20]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(40)
}
[21]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(39)
}
[22]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(39)
}
[23]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(37)
}
[24]=>
array(2) {
["name"]=>
string(12) "Staff hiring"
["count"]=>
int(34)
}
[25]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(32)
}
[26]=>
array(2) {
["name"]=>
string(7) "Layoffs"
["count"]=>
int(32)
}
[27]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(32)
}
[28]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(32)
}
[29]=>
array(2) {
["name"]=>
string(16) "Customer Welfare"
["count"]=>
int(32)
}
}
}
ef866-gb-roche-diagnostics-limited
ROCHE DIAGNOSTICS LIMITED
Location
Founded
1956-09-14
Website
https://diagnostics.roche.com
Articles
3311 Articles
Category
Business Services, Not Elsewhere Classified
Description
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).
For more information, please visit https://careers.roche.com/global/en
Read our community guidelines here:
https://www.roche.com/some-guidelines.htm
#Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation
Monthly infusions of an antibody drug called prasinezumab appear to slow the progression of symptoms in people with advanced Parkinson's disease, Nature Medicine reports.
The 'ranking' of the pharmaceutical companies with the most turnover has changed from one year to the next. In 2023 Johnson & Johnson regained the throne after Pfizer snatched it away a year earlier. The multinational managed to earn 79,906 million, that is, 6.5% more than in 2022 (75,055 million), according to Fierce Pharma.
The U17s won at home after three consecutive defeats. Jean-Baptiste Marty archives After three matches without a victory, the Périgueux U17s found their way back to success with a victory over La Roche-sur-Yon this weekend (33-28).
Barely three years old, and the Roller Derby Gers de Fleurance association is organizing its first “Tournoisol” to compete against the teams from Bayonne, Toulouse and Léon.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
